Arena says addressed FDA concerns on weight loss drug (Reuters)

Reuters – Arena Pharmaceuticals Inc said on Tuesday it submitted data to health regulators that should squash cancer concerns tied to the company’s experimental weight loss drug lorcaserin, and believes it will gain U.S. approval.